<DOC>
	<DOCNO>NCT00212628</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety ONO-5920 patient involutional osteoporosis .</brief_summary>
	<brief_title>Controlled Study ONO-5920 Patients With Involutional Osteoporosis Japan</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>1 . Patients include study ONO592002 complete medication two year 2 . Other inclusion criterion specify study protocol 1 . Patients judge unsuitable safety evaluation clinical trial subject investigator 2 . Patients secondary osteoporosis another condition present low bone mass 3 . Other exclusion criterion specify study protocol</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>ONO-5920</keyword>
	<keyword>osteoporosis</keyword>
	<keyword>bisphosphonate</keyword>
</DOC>